Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Sep;104(1):151–158. doi: 10.1111/j.1476-5381.1991.tb12400.x

Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats.

K Phillips 1, S M Gardiner 1, P A Kemp 1, T Bennett 1
PMCID: PMC1908280  PMID: 1786509

Abstract

1. A series of experiments was performed in conscious, unrestrained, male, Long Evans rats, chronically instrumented for the measurement of regional haemodynamics. 2. Infusion of glyceryl trinitrate (GTN, 0.1 mg kg-1 min-1, i.v.) for 10 min elicited tachycardia, but no sustained change in mean arterial blood pressure. Renal haemodynamics were unaffected, but there were reductions in hindquarters flow and vascular conductance together with substantial increases in flow and conductance in the mesenteric vascular bed. 3. In the presence of captopril (2 mg kg-1 bolus, and 1 mg kg-1 h-1 infusion, i.v.) GTN elicited significant hypotension and increases in renal blood flow and vascular conductance, indicating that activation of the renin-angiotension system opposed the dilator effects of GTN in this vascular bed. However, the mesenteric and hindquarters haemodynamic effects of GTN were not affected by captopril. In contrast, in the presence of enalaprilat (2 mg kg-1 bolus, and 1 mg kg-1 h-1 infusion, i.v.) there was significant enhancement of the mesenteric, as well as renal, haemodynamic effects of GTN. Hence, these results provide no evidence for the sulphydryl groups in captopril exerting a specific effect to enhance the haemodynamic actions of GTN in our experimental protocols. 4. Administration of molsidomine alone (1 mg kg-1, i.v. bolus) elicited tachycardia and hypotension; there were no changes in mesenteric or hindquarters haemodynamics, but renal flow and vascular conductance fell. Thus, the hypotensive effect of molsidomine was probably due to a reduction in cardiac output, consequent upon venodilatation.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
151

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Busse R., Pohl U., Mülsch A., Bassenge E. Modulation of the vasodilator action of SIN-1 by the endothelium. J Cardiovasc Pharmacol. 1989;14 (Suppl 11):S81–S85. doi: 10.1097/00005344-198906152-00015. [DOI] [PubMed] [Google Scholar]
  2. Feelisch M., Ostrowski J., Noack E. On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol. 1989;14 (Suppl 11):S13–S22. [PubMed] [Google Scholar]
  3. Flavahan N. A., Vanhoutte P. M. Mechanism underlying the inhibitory interaction between the nitrovasodilator SIN-1 and the endothelium. J Cardiovasc Pharmacol. 1989;14 (Suppl 11):S86–S90. [PubMed] [Google Scholar]
  4. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol. 1990 Nov;101(3):625–631. doi: 10.1111/j.1476-5381.1990.tb14131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester. Br J Pharmacol. 1990 Nov;101(3):632–639. doi: 10.1111/j.1476-5381.1990.tb14132.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gardiner S. M., Kemp P. A., Bennett T. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol. 1991 Jul;103(3):1725–1732. doi: 10.1111/j.1476-5381.1991.tb09854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gruetter C. A., Lemke S. M. Dissociation of cysteine and glutathione levels from nitroglycerin-induced relaxation. Eur J Pharmacol. 1985 Apr 23;111(1):85–95. doi: 10.1016/0014-2999(85)90116-5. [DOI] [PubMed] [Google Scholar]
  8. Grund E., Müller-Ruchholtz E. R., Lapp E. R., Lösch H. M., Lochner W. Comparative study of nitroglycerin and molsidomine. Effects on the integrated systemic venous bed and the arterial pressure in dogs. Arzneimittelforschung. 1978;28(9):1624–1628. [PubMed] [Google Scholar]
  9. Haywood J. R., Shaffer R. A., Fastenow C., Fink G. D., Brody M. J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981 Aug;241(2):H273–H278. doi: 10.1152/ajpheart.1981.241.2.H273. [DOI] [PubMed] [Google Scholar]
  10. Hogan J. C., Lewis M. J., Henderson A. H. N-acetylcysteine fails to attenuate haemodynamic tolerance to glyceryl trinitrate in healthy volunteers. Br J Clin Pharmacol. 1989 Oct;28(4):421–426. doi: 10.1111/j.1365-2125.1989.tb03522.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ignarro L. J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989 Jul;65(1):1–21. doi: 10.1161/01.res.65.1.1. [DOI] [PubMed] [Google Scholar]
  12. Katz R. J. Mechanisms of nitrate tolerance: a review. Cardiovasc Drugs Ther. 1990 Feb;4(1):247–252. doi: 10.1007/BF01857640. [DOI] [PubMed] [Google Scholar]
  13. Kawamoto J. H., McLaughlin B. E., Brien J. F., Marks G. S., Nakatsu K. Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilation. J Cardiovasc Pharmacol. 1990 May;15(5):714–719. doi: 10.1097/00005344-199005000-00005. [DOI] [PubMed] [Google Scholar]
  14. Kiff R. J., Gardiner S. M., Compton A. M., Bennett T. Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol. 1991 Jun;103(2):1357–1362. doi: 10.1111/j.1476-5381.1991.tb09793.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lüscher T. F., Richard V., Yang Z. H. Interaction between endothelium-derived nitric oxide and SIN-1 in human and porcine blood vessels. J Cardiovasc Pharmacol. 1989;14 (Suppl 11):S76–S80. [PubMed] [Google Scholar]
  16. McMurray J., Chopra M. Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope? Br J Clin Pharmacol. 1991 Apr;31(4):373–379. doi: 10.1111/j.1365-2125.1991.tb05549.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moncada S., Palmer R. M., Higgs E. A. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 1988 Oct;12(4):365–372. doi: 10.1161/01.hyp.12.4.365. [DOI] [PubMed] [Google Scholar]
  18. Moncada S., Rees D. D., Schulz R., Palmer R. M. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2166–2170. doi: 10.1073/pnas.88.6.2166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Moore P. K., al-Swayeh O. A., Chong N. W., Evans R. A., Gibson A. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol. 1990 Feb;99(2):408–412. doi: 10.1111/j.1476-5381.1990.tb14717.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Muller A. F., Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats. Clin Sci (Lond) 1990 Oct;79(4):393–401. doi: 10.1042/cs0790393. [DOI] [PubMed] [Google Scholar]
  21. Newman C. M., Warren J. B., Taylor G. W., Boobis A. R., Davies D. S. Rapid tolerance to the hypotensive effects of glyceryl trinitrate in the rat: prevention by N-acetyl-L- but not N-acetyl-D-cysteine. Br J Pharmacol. 1990 Apr;99(4):825–829. doi: 10.1111/j.1476-5381.1990.tb13014.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  23. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  24. Rees D. D., Palmer R. M., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990 Nov;101(3):746–752. doi: 10.1111/j.1476-5381.1990.tb14151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stewart D. J., Münzel T., Holtz J., Bassenge E. Discrepancy between initial and steady-state resistance vessel responsiveness to short-term nitroglycerin exposure in the hindlimb of conscious dogs. J Cardiovasc Pharmacol. 1988 Aug;12(2):144–151. doi: 10.1097/00005344-198808000-00004. [DOI] [PubMed] [Google Scholar]
  26. Theodorsson-Norheim E. Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput Biol Med. 1987;17(2):85–99. doi: 10.1016/0010-4825(87)90003-5. [DOI] [PubMed] [Google Scholar]
  27. Wilson I. D., Watson K. V., Troke J., Illing H. P., Fromson J. M. The metabolism of [14C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in laboratory animals. Xenobiotica. 1986 Dec;16(12):1117–1128. doi: 10.3109/00498258609038989. [DOI] [PubMed] [Google Scholar]
  28. van Gilst W. H., de Graeff P. A., Scholtens E., de Langen C. D., Wesseling H. Potentiation of isosorbide dinitrate-induced coronary dilatation by captopril. J Cardiovasc Pharmacol. 1987 Feb;9(2):254–255. doi: 10.1097/00005344-198702000-00021. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES